Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

BACKGROUND: Patients with malignant mesothelioma have a poor prognosis and only 40% respond to first line treatment; a combination of pemetrexed and cisplatin or carboplatin. We used primary malignant mesothelioma cells and an ex vivo chemosensitivity assay with future purpose to predict best choice...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Szulkin, Adam, Ötvös, Rita, Hillerdal, Carl-Olof, Celep, Aytekin, Yousef-Fadhel, Eviane, Skribek, Henriette, Hjerpe, Anders, Székely, László, Dobra, Katalin
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190467/
https://ncbi.nlm.nih.gov/pubmed/25253633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-709
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires